Bioelectronic Medicine The New Frontier Of Inflammatory Disease Treatment

Bioelectronic Medicine The New Frontier Of Inflammatory Disease Treatment
The rapid pace of technological evolution over the past several decades has dramatically changed the way we live and work, and it is also changing the way medicine is practiced. The convergence of technology, molecular medicine and molecular biology will enable development of devices and technologies to catalyze advances in mechanistic understanding of disease. Individuals positioned to lead this effort are at the spearpoint of where molecular biology meets technology and will be creating a revolutionary new future: bioelectronic medicine. FeinsteinINst   The Manhasset, New York based Feinstein Institute for Medical Research -- the research arm of the North Shore-LIJ Health System, in cooperation with SetPoint Medical Inc., a Valencia, California-based biomedical technology company, have released research results on the therapeutic potential of vagus nerve stimulation. In a paper published in the journal Bioelectronic Medicine, the Feinstein Institute for Medical Research's president and CEO Kevin J. Tracey, MD, and his colleagues at the Institute, explore how low-level electrical stimulation interacts with the body's nerves to reduce inflammation, a fundamental goal of bioelectronic medicine. Prior to this study, it was not understood which vagus nerve fiber types were responsible for reducing the body's inflammatory activity. The Bioelectronic Medicine paper's findings indicate
Subscribe or to access all post and page content.